DRKS00033127
Completed
未知
Pharmacist-assisted implementation of guideline recommendations for QTc monitoring during psychopharmacotherapy - a prospective, randomised feasibility study - PHARMQT
Zentrum für Integrative Psychiatrie0 sites160 target enrollmentNovember 28, 2023
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- R94.3
- Sponsor
- Zentrum für Integrative Psychiatrie
- Enrollment
- 160
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Admission to wards B3\.01, B3\.11, B6\.01 and to the day clinic B22
- •\- Expected length of stay at least 30 days
- •\- Use of at least one QT\-prolonging drug during the stay (known, possible or conditional risk according to CredibleMeds)
- •\- Signed declaration of consent
Exclusion Criteria
- •\- Patients who are not taking a QT\-prolonging drug during the study period
- •\- Patients who sleep on the psychiatric wards but who are hospitalized for somatic treatment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Impact of Pharmaceutical care in heart failure patientsHealth Condition 1: I501- Left ventricular failure, unspecifiedCTRI/2022/10/046436Dr Anu Philip
Not yet recruiting
Not Applicable
Implementation of Clinical Practice Guidelines for the Physiotherapy Management of People with Spinal Cord InjurySpinal Cord InjuryNeurological - Other neurological disordersPublic Health - Health service researchPhysical Medicine / Rehabilitation - PhysiotherapyInjuries and Accidents - Other injuries and accidentsACTRN12623001106628orthern Sydney Local Health District10
Not yet recruiting
Not Applicable
Pharmacist led decision support protocol for the management of anaemia utilising erythrocyte stimulating agents in patients undergoing haemodialysis.anaemia in renal diseaseACTRN12618000189224niversity of Queensland72
Completed
Not Applicable
Development of intervention tool and its effect on health care of patients with dyslipidemia by community pharmacistsDyslipidemiaJPRN-UMIN000044945Showa University40
Not yet recruiting
Not Applicable
A combined, tailored pharmacist intervention with dose optimization of phosphate binding drugs to improve phosphate control in patients on dialysis.NL-OMON24286Franciscus Gasthuis and Vlietland45